Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 3/2012

01-09-2012

Fine Needle Aspiration Biopsy of an Unusual Follicular Adenoma with Sebaceous-Like Features

Authors: Jacob R. Bledsoe, Peter M. Sadow, Antonia Stephen, G. Petur Nielsen, William C. Faquin

Published in: Endocrine Pathology | Issue 3/2012

Login to get access

Excerpt

Fine needle aspiration biopsy (FNAB) is a safe, accurate, and cost effective tool for the initial management of thyroid nodules [1‐4]. The mean reported accuracy of thyroid FNAB is over 76 %, with a range from 53 to 95 % [5, 6]. A variety of factors can lead to diagnostic errors in the evaluation of thyroid FNABs. One feature that can be a diagnostic challenge is the presence of cells with clear cytoplasm. Such clear cell features can be seen in benign thyroid lesions as well as in more clinically significant entities that include metastasis from a primarily clear cell malignancy such as clear cell renal cell carcinoma. …
Literature
1.
Bongiovanni M, Cibas ES, Faquin WC. The role of thyroid fine needle aspiration cytology and the Bethesda system for reporting thyroid cytopathology. Diagn Histopathol 2011; 17(3): 95–105.CrossRef
2.
Lundgren CI, Zedenius J, Skoog L. Fine-needle aspiration biopsy of benign thyroid nodules: an evidence-based review. World J Surg 2008; 32: 1247–52.PubMedCrossRef
3.
4.
Werga P, Wallin G, Skoog L, Hamberger B. Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management. World J Surg 2000; 24: 907–12.PubMedCrossRef
5.
Lewis CM, Chang KP, Pitman M, Faquin WC, Randolph GW. Thyroid fine-needle aspiration biopsy: variability in reporting. Thyroid 2009; 19: 717–23.PubMedCrossRef
6.
Bukhari MH, Niazi S, Hanif G, et al. An updated audit of fine needle aspiration cytology procedure of solitary thyroid nodule. Diagn Cytopathol 2008; 36: 104–12.PubMedCrossRef
7.
Carcangiu ML, Sibley RK, Rosai J. Clear cell change in primary thyroid tumors—a study of 38 cases. Am J Surg Pathol 1985; 9(10): 705–722.PubMedCrossRef
8.
Gulwani H, Chopra P. Mucin-producing signet ring cell adenoma of the thyroid. Indian J Pathol Microbiol 2008; 51(4): 507–508.PubMedCrossRef
9.
Yoshida J, Tanimura A, Yamashita H, Matsuo K. Signet ring cell adenoma of the thyroid with mucin predominance. Thyroid 1999; 9(4): 401–404.PubMedCrossRef
10.
Ishimaru Y, Fukuda S, Kurano R, Miura K, Tajiri J, et al. Follicular thyroid carcinoma with clear cell change showing unusual ultrastructural features. Am J Surg Pathol 1988; 12(3): 240–246.PubMedCrossRef
11.
Ng W, Tang V, Poon C. Fine needle aspiration cytology of follicular carcinoma with clear cell change—a case report. Acta Cytologica 2002; 46(4): 757–761.PubMedCrossRef
12.
Schröder S, Hüsselmann H, Böcker W. Lipid-rich cell adenoma of the thyroid gland—report of a peculiar thyroid tumour. Virchows Arch A Pathol Anat Histopathol 1984; 404(1): 105–8.PubMedCrossRef
13.
Rath-Wolfson L, Leikin A, Hilly O, Rumelia K, Rivka G. Follicular lesions—carcinoma and adenoma of the thyroid, lipid rich type. Conexiuni Medicale 2010; 3(19): 107–114.
14.
Toth K, Peter I, Kremmer T, Sugar J. Lipid-rich cell thyroid adenoma: histopathology with comparative lipid analysis. Virchows Arch A Pathol Anat Histopathol 1990; 417(3): 273–276.PubMedCrossRef
15.
Ranaldi R, Goteri G, Bearzi I. Lipid-rich adenoma of the thyroid. Pathol Res Prac 1993; 189: 1101–7.CrossRef
16.
Chetty R. Thyroid follicular adenoma composed of lipid-rich cells. Endocr Pathol 2011; 22(1): 31–34.PubMedCrossRef
17.
Yang GCH, Yao JL, Feiner HD, Roses DF, Kumar A, et al. Lipid-rich follicular carcinoma of the thyroid in a patient with McCune–Albright syndrome. Mod Pathol 1999; 12(10): 969–73.PubMed
18.
Gnepp DR, Ogorzalek JM, Heffess CS. Fat-containing lesions of the thyroid gland. Am J Surg Pathol 1989; 13(7): 605–12.PubMedCrossRef
19.
Heffess CS, Wenig BM, Thompson LD. Metastatic renal cell carcinoma to the thyroid gland: a clinicopathologic study of 36 cases. Cancer 2002; 95(9): 1869–1878.PubMedCrossRef
Metadata
Title
Fine Needle Aspiration Biopsy of an Unusual Follicular Adenoma with Sebaceous-Like Features
Authors
Jacob R. Bledsoe
Peter M. Sadow
Antonia Stephen
G. Petur Nielsen
William C. Faquin
Publication date
01-09-2012
Publisher
Springer US
Published in
Endocrine Pathology / Issue 3/2012
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-012-9205-z

Other articles of this Issue 3/2012

Endocrine Pathology 3/2012 Go to the issue

Report

Unusual Type of Growth Hormone-Producing Pituitary Tumor in Acromegaly

Report

Relapse of Acute Myeloid Leukemia at the Pituitary Gland: A Case Report and Review of Literature

Report

Water-Clear Parathyroid Adenoma: Report of Two Cases and Literature Review

OriginalPaper

Cell-Type-Specific Expression of STAT Transcription Factors in Tissue Samples from Patients with Lymphocytic Thyroiditis

OriginalPaper

The Relationship of the BRAFV600E Mutation and the Established Prognostic Factors in Papillary Thyroid Carcinomas

Report

ACTH-Secreting Pheochromocytoma with False-Negative ACTH Immunohistochemistry
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits